Moelis & Company (MC) - Kelajakdagi narxning foydaga nisbati

Moelis Corp - MC emitenti grafik logotipi

Moelis & Company (MC) tashqi IT pudratchilarga bog'liqlikni minimallashtirgan holda, ichki ekspertlarga tayanadi. Ushbu avtonomiya global huquqshunoslar bilan murakkab restrukturizatsiyalarning samarali muvofiqlashtirilishini ta'minlaydi va GURU.Markets terminalining chiziqli grafigidagi kompaniyaning forward P/E qiymati metrikaning holatini ifodalovchi 14.90 ko'rsatkichini o'z ichiga oladi. Barqaror raqobatbardoshlik ustunligi va elita M&A butikining nufuzi biznesni yirik moliyaviy gigantlarning bosimidan himoya qiladi.

Prognoz qilingan narx-foyda nisbati: Moelis & Company Group (MC) 04.07.2022 - 17.11.2026 uchun

Moelis & Company (MC) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy narx va aksiyalarning prognoz qilingan qiymati:
- bozor kapitallashuvi ko'rsatkichlari:
Kompaniyaning fundamental tahlili:Moelis Corp
Moelis Corp brend mahsuloti

Forward P/E joriy bozor ulushi narxining kutilayotgan sof foyda miqdoriga nisbati sifatida hisoblanadi, bu esa investorga kutilayotgan daromadning bir birligi uchun xarajatlarni baholash imkonini beradi. Biznesning kutilayotgan P/E ko'rsatkichini tahlil qilish orqali, bozor kutuvlarini butik M&A konsalting samaradorligi va Moelis & Company (MC) ofis infratuzilmasi xarajatlari bilan solishtirib, kapital risklarini o'z vaqtida yumshatish yoki tendentsiyani mustahkamlash mumkin.

Asosiy raqobatchilar

Kelajakdagi narxning foydaga nisbati cintas.com (CTAS)|Forvard P/E multiplikatori Thomson Reuters (TRI)|Houlihan Lokey Corp - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati BAH (boozallen.com)|RTO - Kelajakdagi narxning foydaga nisbati|ExlService Holdings, Inc. - Kapitalizatsiyaning kelajakdagi foydaga nisbati|pjtpartners.com (PJT) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati FTI Consulting, Inc. (FCN)|Kelajakdagi narxning foydaga nisbati Concentrix Corp|Prognoz qilingan narx-foyda nisbati Exponent EXPO|Kelajakdagi narxning foydaga nisbati WNS Holdings (WNS)|CBZ (CBIZ) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABM (ABM Industries)|TIC - Prognoz qilingan narxning foydaga nisbati|LZ - Kelajakdagi narxning foydaga nisbati|ICF International, Inc. (ICFI) - Prognoz qilingan narxning foydaga nisbati|TASK: Forvard P/E multiplikatori|WLDN - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati CRA International, Inc.|Narxning kelajakdagi foydaga nisbati TIXT (TELUS International Inc)|Forvard P/E multiplikatori DLX|performantcorp.com (PHLT) - Forvard narx-foyda multiplikatori|The Hackett Group, Inc. - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning prognoz qilingan foydaga nisbati IBEX Corp (IBEX)|Rich Sparkle Corp - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori XRX (Xerox Corporation)|Conduent (CNDT) - Kelajakdagi narxning foydaga nisbati|Forvard narx-foyda multiplikatori kingsway-financial.com KFS|INV (Innventure Group) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati LPRO (Open Lending Corp)|Prognoz qilingan narxning foydaga nisbati RCMT (RCM Technologies, Inc.)|TTEC (TTEC Holdings) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori RGP (Resources Connection)|Kapitalizatsiyaning kelajakdagi foydaga nisbati EGG (Enigmatig Limited)|TISI - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori PMEC (Primech Holdings Limited)|ACCESS Newswire Inc (ACCS) - Kelajakdagi narxning foydaga nisbati|Narxning kelajakdagi foydaga nisbati HHS|Prognoz qilingan narxning foydaga nisbati RYOJ|Kelajakdagi narxning foydaga nisbati SPPL|Forvard P/E multiplikatori GRNQ|Top KingWin - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori QH (quhuo.cn)|Kelajakdagi narx-foyda multiplikatori PMAX|Lichen China Corp - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati Bluemount Holdings|zenta.com.mo (ZGM) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Hang Feng Fintech|Kelajakdagi narxning foydaga nisbati ARC Document Solutions Inc|Prognoz qilingan narxning foydaga nisbati GSE Systems (GVP)|NVEE (NV5 Global, Inc.) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori performantcorp.com (PFMT)|Forvard P/E multiplikatori STER (Sterling Check Corp.)|Kelajakdagi narx-foyda multiplikatori TDCX